133 related articles for article (PubMed ID: 14764029)
1. The influence of splenic metastases on survival in FIGO stage IIIC epithelial ovarian cancer.
Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
Int J Gynecol Cancer; 2004; 14(1):51-6. PubMed ID: 14764029
[TBL] [Abstract][Full Text] [Related]
2. Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience.
Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
Anticancer Res; 2015 Oct; 35(10):5649-54. PubMed ID: 26408738
[TBL] [Abstract][Full Text] [Related]
3. [Splenectomy in epithelial ovarian cancer: analysis of 32 cases].
Zheng AW; Zheng F; Chen YQ; Zhu HN; Qian JH
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):197-200. PubMed ID: 18788569
[TBL] [Abstract][Full Text] [Related]
4. Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer.
Xiang L; Tu Y; He T; Shen X; Li Z; Wu X; Yang H
J Gynecol Oncol; 2016 Nov; 27(6):e62. PubMed ID: 27550408
[TBL] [Abstract][Full Text] [Related]
5. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
6. Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancer.
Tanner EJ; Long KC; Feffer JB; Leitao MM; Abu-Rustum NR; Barakat RR; Chi DS; Gardner GJ
Gynecol Oncol; 2013 Jan; 128(1):28-33. PubMed ID: 23017819
[TBL] [Abstract][Full Text] [Related]
7. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study.
Eisenkop SM; Friedman RL; Wang HJ
Gynecol Oncol; 1998 May; 69(2):103-8. PubMed ID: 9600815
[TBL] [Abstract][Full Text] [Related]
8. Splenectomy in recurrent epithelial ovarian cancer.
Gemignani ML; Chi DS; Gurin CC; Curtin JP; Barakat RR
Gynecol Oncol; 1999 Mar; 72(3):407-10. PubMed ID: 10053114
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic splenectomy for solitary splenic metastasis in a patient with ovarian cancer with a long disease-free interval: a case report.
Yasuda K; Yoshimura T; Kitade H; Yanagida H; Hosaka N
J Med Case Rep; 2018 May; 12(1):132. PubMed ID: 29759073
[TBL] [Abstract][Full Text] [Related]
10. Splenic metastases--not a frequent problem, but an underestimate location of metastases: epidemiology and course.
Sauer J; Sobolewski K; Dommisch K
J Cancer Res Clin Oncol; 2009 May; 135(5):667-71. PubMed ID: 18936972
[TBL] [Abstract][Full Text] [Related]
11. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
[TBL] [Abstract][Full Text] [Related]
12. What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.
Rungruang BJ; Miller A; Krivak TC; Horowitz NS; Rodriguez N; Hamilton CA; Backes FJ; Carson LF; Friedlander M; Mutch DG; Goodheart MJ; Tewari KS; Wenham RM; Bookman MA; Maxwell GL; Richard SD
Cancer; 2017 May; 123(6):985-993. PubMed ID: 27864921
[TBL] [Abstract][Full Text] [Related]
13. Correlation between macroscopic and microscopic diseases on splenectomies performed in the surgical management of ovarian cancer.
Uzan C; Bontoux LM; Gouy S; Duvillard P; Pautier P; Lhommé C; Morice P
Int J Gynecol Cancer; 2010 Aug; 20(6):965-70. PubMed ID: 20683403
[TBL] [Abstract][Full Text] [Related]
14. Splenectomy as Part of Cytoreductive Surgery in Recurrent Epithelial Ovarian Cancer.
Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
Anticancer Res; 2015 Sep; 35(9):5097-101. PubMed ID: 26254413
[TBL] [Abstract][Full Text] [Related]
15. Advanced epithelial ovarian carcinoma: long-term survival experience at the community hospital.
Unzelman RF
Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 1):1663-71; discussion 1671-2. PubMed ID: 1615973
[TBL] [Abstract][Full Text] [Related]
16. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
[TBL] [Abstract][Full Text] [Related]
17. Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer.
Eisenkop SM; Spirtos NM; Lin WC
Gynecol Oncol; 2006 Feb; 100(2):344-8. PubMed ID: 16202446
[TBL] [Abstract][Full Text] [Related]
18. Splenectomy during secondary cytoreductive surgery for epithelial ovarian cancer.
Hanprasertpong J; Ohishi R; Iwasa N; Nagao S; Okamoto K; Fujiwara K
Asian Pac J Cancer Prev; 2010; 11(2):413-6. PubMed ID: 20843126
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic Splenectomy as Quaternary Cytoreduction for Isolated Parenchymal Splenic Recurrence of Epitelial Tubo-Ovarian Cancer: Report of a Case and Literature Review.
Sorbi F; Prosperi P; Villanucci A; Berti V; Sisti G; Fambrini M
Gynecol Obstet Invest; 2015; 80(4):265-71. PubMed ID: 25677585
[TBL] [Abstract][Full Text] [Related]
20. Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator.
Bristow RE; Montz FJ
Gynecol Oncol; 2001 Oct; 83(1):39-48. PubMed ID: 11585412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
